Penny Fang, MD, MBA
Department of Radiation Oncology, Division of Radiation Oncology
About Dr. Penny Fang
Dr. Penny Fang is in the Department of Radiation Oncology at the University of Texas MD Anderson Cancer Center. Before her appointment as faculty, she received her BS, summa cum laude , from Harvard University, her MD from the University of Pennsylvania and completed residency training in Radiation Oncology at MD Anderson Cancer Center.
Her clinical expertise is in the treatment of lymphoma, leukemia, and other hematologic malignancies. In clinical practice, she emphasizes a compassionate, innovative, and individualized approach to patient care. Dr. Fang's research interests are in translational and clinical trials for lymphoma patients to improve cure rates and other treatment outcomes. Her research incorporates the use of immunologic, molecular, and radiologic biomarkers to understand and predict why cancer patients respond differently to therapies in order to deliver the right treatment to the right patient at the right time and investigate novel ways of optimizing treatment for individual patients with hematologic malignancies.
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Clinical Sciences, Division of Radiation Oncology, University of Houston College of Medicine, Houston, TX
Assistant Professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Assistant Professor, Department of Clinical Sciences, University of Houston College of Medicine, Houston, TX
Assistant Professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2014 | University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, US, MD |
| 2014 | The Wharton School, University of Pennsylvania, Philadelphia, Pennsylvania, US, Healthcare Management, MBA |
| 2009 | Harvard University, Cambridge, Massachusetts, US, Neurobiology, BS |
Postgraduate Training
| 2015-2019 | Clinical Residency, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2014-2015 | Clinical Internship, Preliminary Internal Medicine, University of Chicago, Chicago, Illinois |
Board Certifications
| 2021 | American Board of Radiology |
Experience & Service
Administrative Appointments/Responsibilities
Hematologic Malignancies Medical Student Education Site Director, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2023 - Present
Associate Director of Clinical Research, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - Present
Institutional Committee Activities
Site Director, Hematologic Malignancies Radiation Oncology Medical Student Education, 2023 - Present
Member, MD Anderson Data and Safety Monitoring Committee (DSMC), 2023 - Present
Member, ROSI John and Cher Floyd Prostate Cancer Research Award Scientific Review Committee, 2023 - 2024
Member, Department of Radiation Oncology Department Administrator Search Committee, 2023 - Present
Co-Chair, Lymphoma/Myeloma Grand Rounds Planning Committee, 2023 - Present
Member, Department of Radiation Oncology Director of Physician Scientist Program Search Committee, 2022 - 2023
Member, Radiation Oncology Clinical Trials Scientific Review Committee, 2022 - Present
Member, ROSI Clinical Trials Seed Award Scientific Review Committee, 2022 - Present
Chair, Clinical Trials Data Governance and Quality Committee, Radiation Oncology, 2022 - Present
Chair, Radiation Oncology New Protocol Activation Review Committee, 2022 - Present
Associate Director, Division of Radiation Oncology Clinical Research, 2022 - Present
Member, MD Anderson Cancer Center Plasma Cell Neoplasm: Multiple Myeloma and Solitary Plasmacytoma Clinical Guidelines Working Group, 2022 - Present
Member, Education RFA Scientific Review Committee, 2021 - 2022
Member, Boot Walk Non-Faculty Seed Award Scientific Review Committee, 2021 - 2021
Member, Radiation Oncology Shark Tank Scientific Review Committee, 2020 - 2021
Member, MD Anderson Houston Area Locations Clinical Guidelines and Research Protocol Review, 2020 - Present
Member, MD Anderson Aggressive Lymphoma Research Working Group, 2019 - Present
Member, MD Anderson Indolent Lymphoma Research Working Group, 2019 - Present
Member, Radiation Oncology Grand Rounds Committee, 2019 - Present
Faculty Mentor, Radiation Oncology Medical Student Mentorship Program, 2019 - Present
Member, MD Anderson Epic EHR Hematologic Malignancies Committee, 2019 - Present
Curriculum Chair, MD Anderson Residency Program, 2017 - 2018
Vice President, House Staff Senate, 2016 - 2017
Physician Representative, Radiation Oncology Time-Derived Activity Based Costing Project, 2016 - 2017
Project Leader, Clinical Quality Improvement Project, Urgent/Emergent Radiation Team Hand-off Communication, 2016 - 2017
Chair, Radiation Oncology Residency Improvement Committee, 2016 - 2017
Honors & Awards
| Harvard Research Award | |
| Summa Cum Laude with highest honors, Neurobiology, Harvard | |
| John Harvard Scholar Award for Academic Distinction, Top 5% of class, Harvard | |
| Harvard Senior Thesis Award, Highest Departmental Honors for Research Thesis: Towards an in-vitro stem cell model for Alzheimer's disease | |
| Harvard Phi Beta Kappa Honor Society Induction | |
| National Institute of Diabetes and Digestive and Kidney Diseases Research Award, National Institutes of Health | |
| Wharton Palmer Scholar Award (Top 5% of graduating class) | |
| Wharton Director's List Academic Honors Award | |
| Rose Meadow Levinson Prize for Outstanding Cancer Research, University of Pennsylvania School of Medicine | |
| Young Oncologist Travel Grant Award, American Radium Society | |
| RSNA Resident Research Grant Award | |
| MD Anderson Mary Fletcher Heart of Caring Memorial Award for Clinical Excellence | |
| American Society for Radiation Oncology Annual Meeting Abstract Award | |
| RSNA Roentgen Resident Research Award | |
| James D. Cox Award, Gilbert Fletcher Society Research Competition Award | |
| American Radium Society Young Oncologist Essay Award | |
| ASCO Young Investigator Award | |
| A. Lavoy Moore Endowed Fellowship Award, MD Anderson Cancer Center | |
| Best of ASTRO Abstract, A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue Lymphoma, American Society for Therapeutic Radiation Oncology | |
| ROC-STaR Award, MD Anderson Cancer Center, Radiation Oncology | |
| ROC-STaR Award (recognition for clinical abilities, kindness, dedication to patients), MD Anderson Cancer Center, Radiation Oncology |
Selected Publications
Peer-Reviewed Articles
- Manzar GS, Wu SY, Dudzinski SO, Yoder AK, Corrigan KL, Cha EE, Nasr LF, Sallard G, Ahmed S, Fayad LE, Chihara D, Nair R, Westin JR, Daher M, Neelapu SS, Nastoupil LJ, Gunther JR, Pinnix CC, Dabaja BS, Strati P, Fang PQ. Characterization of lymphopenia and correlating the risk of cytopenias with dose and bone marrow volume irradiated in aggressive B-cell lymphoma patients bridged with radiation therapy for CAR-T cell therapy. Int J Radiat Oncol Biol Phys 121(4):1011-1025, 2025. e-Pub 2025. PMID: 39303997.
- Wu, SY, Damron, EP, Xu, J, Fang, PQ, Dai, J, Nair, R, Malpica Castillo, LE, Fayad, LE, Torres Cabala, CA, Medeiros, LJ, Vega Vazquez, F, Miranda, R, Duvic, M, Pinnix, CC, Dabaja, BS, Iyer, S, Huen, A, Gunther, J. Radiotherapy in the treatment of primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder. Int J Dermatol 64(2):385-389, 2025. e-Pub 2025. PMID: 38955474.
- Manzar GS, Pinnix CC, Dudzinski SO, Marqueen KE, Cha E, Nasr LF, Yoder AK, Rooney MK, Strati P, Ahmed S, Nze CC, Nair R, Fayad L, Wang M, Nastoupil LJ, Westin JR, Flowers CR, Neelapu SS, Gunther J, Wu S, Fang P. Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas. Front Immunol 16(None):None. e-Pub 2025. PMID: 39958356.
- Fang, PQ, Noticewala, SS, Wu, SY, Gunther, J, Ludmir, EB, Medeiros, LJ, Strati, P, Nair, R, Nze, CC, Nastoupil, L, Ahmed, S, Castillo, LM, Fayad, LE, Westin, J, Neelapu, SS, Flowers, CR, Huen, A, Iyer, SP, Dabaja, BS, Pinnix, CC. Early-Stage Extranodal NK/T-Cell Lymphoma, Nasal Type. Advances in Radiation Oncology 9(12), 2024. e-Pub 2024. PMID: 39553398.
- Wu, SY, Fang, PQ, Fetooh, A, Manzar, G, Corrigan, KL, Schrank, BR, Nasr, L, Chihara, D, Castillo, LM, Nair, R, Steiner, RE, Jain, P, Neelapu, SS, Strati, P, Nastoupil, L, Dabaja, BS, Pinnix, CC, Gunther, J. Ultra–Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung. Advances in Radiation Oncology 9(12), 2024. e-Pub 2024. PMID: 39524525.
- Manzar GS, Dudzkinski SO, Yoder AK, Seo A, Nasr LF, Rafei H, Becnel MR, Patel KK, Lee HC, Kaufman GP, Gaballa MM, Ye JC, Saini N, Thomas SK, Amini B, Orlowski RZ, Dabaja BS, Pinnix CC, Gunther JR, Wu SY, Fang PQ. Outcome of patients with central nervous system multiple myeloma (CNS-MM) treated with CNS-directed radiation therapy. Clin Lymphoma Myeloma Leuk None(None):None. e-Pub 2024. PMID: 39709251.
- Pinnix CC, Dabaja BS, Gunther J, Fang P, Wu S, Nastoupil L, Strati P, Nair R, Ahmed S, Steiner R, Westin J, Neelapu S, Rodriguez MA, Lee HJ, Wang M, Flowers C, Feng L, Esmaeli B. Response-Adapted Ultra-Low-Dose Radiation Therapy for Orbital Indolent B-cell Lymphoma. JAMA Oncology 10(9):1195-1203, 2024. e-Pub 2024. PMID: 38990564.
- Manzar, G, Cha, E, Corrigan, KL, Yoder, A, Schrank, BR, Nasr, L, Chihara, D, Castillo, LM, Nair, R, Jain, P, Neelapu, SS, Rodriguez, MA, Strati, P, Nastoupil, L, Gunther, J, Dabaja, BS, Pinnix, CC, Wu, SY, Fang, PQ. Outcomes and toxicities in patients with diffuse-large B cell lymphoma involving the gastrointestinal tract and digestive organs. Frontiers in Oncology 14, 2024. e-Pub 2024. PMID: 39324011.
- Zhang JR, Wu SY, Jain P, Oki CY, Yan F, Chen W, Oriabure O, Dabaja BS, Gunther JR, Fang P, Pinnix CC, Wang M, Gaulin C. Characteristics, Treatment, and Outcomes of Mantle Cell Lymphoma with Cutaneous Involvement: A Decade-Long Study at MD Anderson Cancer Center. Leukemia and Lymphoma None(None):None, 2024. e-Pub 2024. PMID: None.
- Gunther JR, Xu J, Bhutani MS, Strati P, Fang PQ, Wu SY, Dabaja BS, Dong W, Bhosale PR, Flowers CR, Nair R, Malpica Castillo L, Fayad L, Iyer SP, Parmer S, Wang M, Lee HJ, Samaniego F, Westin J, Ahmed S, Nze CC, Jain P, Neelapu SS, Rodriguez MA, Chihara D, Nastoupil LJ, Pinnix CC. Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial. Lancet Haematol 11(7):e521-e529, 2024. e-Pub 2024. PMID: 38843856.
- Lin S, Subbiah V, Cohen EN, Li Z, Lu YJ, Son YL, Lyu Y, Gao H, Jayachandran G, Neri S, Sharma A, Fang P, Karp D, Hong D, Rodon J, Yu H, Peng J, Lloyd G, Tonra JR, Reuben JM, Huang L, Fu S. Plinabulin Following Radiation Enhances Dendritic Cell Maturation and Checkpoint Inhibitor Retreatment of Relapsed/Refractory Cancers. Cancer Cell None(None):None. e-Pub 2024. PMID: None.
- Fang P, Pinnix CC, Wu SY, Lee HC, Patel KK, Saini N, Becnel MR, Kaufman G, Thomas SK, Orlowski RZ, Amini B, Lin P, Dabaja BS, Gunther JR. Management and Outcomes of Patients with Refractory Solitary Plasmacytoma after Treatment with Definitive Radiation Therapy. Int J Radiat Oncol Biol Phys 119(1):193-199, 2024. e-Pub 2024. PMID: 38070713.
- Steiner RE, Hwang SR, Khurana A, Habermann TM, Epperla N, Annunzio K, Allen PB, Baird K, Paulino D, Alderuccio JP, Lossos IS, David K, Evens AM, Pandya K, Bair SM, Kamdar M, Ba Aqeel S, Torka P, Lynch R, Smith S, Feng L, Noorani M, Ahmed S, Nair R, Vega F, Wu S, Fang P, Pinnix CC, Gunther JR, Dabaja BS, Lee HJ. Impact of Cumulative Dose of Brentuximab Vedotin on Outcomes of Frontline Therapy for Advanced Stage Hodgkin Lymphoma. Blood Adv 7(24):7485-7493, 2023. e-Pub 2023. PMID: 37603594.
- Wu SY, Fang PQ, Wang EB, Ahmed S, Duvic M, Jain P, Castillo LEM, Nair R, Steiner RE, Strati P, Huen AO, Iyer SP, Pinnix CC, Dabaja BS, Gunther JR. Safety of Concurrent Radiation Therapy with Brentuximab Vedotin in the Treatment of Lymphoma. Adv Radiat Oncol 8(6):101279, 2023. e-Pub 2023. PMID: 37448588.
- Reddy JP, Lei X, Bloom ES, Reed VK, Schlembach PJ, Arzu I, Mayo L, Chun SG, Ahmad NR, Stauder MC, Gopal R, Kaiser K, Fang P, Smith BD, Investigators OT. Optimizing Preventive Adjuvant Linac-Based (OPAL) Radiation: A Phase II Trial of Daily Partial Breast Irradiation. Int J Radiat Oncol Biol Phys 115(3):629-644, 2023. e-Pub 2023. PMID: 36216274.
- Damron EP, Qazilbash MH, Fang PQ, Wu SY, Dabaja BS, Rondon G, Hosing C, Champlin RE, Bashir Q, Shpall EJ, Knafl MK, Lee HC, Manasanch EE, Patel K, Thomas SK, Orlowski RZ, Weber DM, Pinnix CC, Gunther JR. Radiation Therapy Can Be Safely Incorporated into Pretransplantation Treatment Regimens for Patients with Multiple Myeloma. Transplant Cell Ther 29(1):37.e1-37.e7, 2023. e-Pub 2023. PMID: 37753818.
- Wu SY, Short NJ, Nasr L, Dabaja BS, Fang PQ. Central Nervous System Prophylaxis and Treatment in Acute Leukemias. Curr Treat Options Oncol 23(12):1829-1844, 2022. e-Pub 2022. PMID: 36510037.
- Dabaja BS, Boyce-Fappiano D, Dong W, Damron E, Fang P, Gunther J, Rodriguez MA, Strati P, Steiner R, Nair R, Lee H, Abou Yehia Z, Shihadeh F, Pinnix C, Ng AK. Second malignancies in patients with Hodgkin's Lymphoma: Half a century of experience. Clin Transl Radiat Oncol 35(None):64-69, 2022. e-Pub 2022. PMID: 35601797.
- Moningi S, Lei X, Fang P, Taniguchi CM, Holliday EB, Koay EJ, Koong AC, Ludmir EB, Minsky BD, Das P, Giordano SH, Smith GL. Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer. Clin Transl Radiat Oncol 35(None):9-16, 2022. e-Pub 2022. PMID: 35510142.
- Bao, A, Barsky, AR, Maxwell, R, Bekelman, JE, Both, S, Christodouleas, JP, Deville, C, Fang, PQ, Tochner, Z, Vapiwala, N. Long-term Clinical Outcomes in Favorable Risk Prostate Cancer Patients Receiving Proton Beam Therapy. International Journal of Particle Therapy 8(4):14-24, 2022. e-Pub 2022. PMID: 35530185.
- Nguyen CN, Iyer SP, Miranda RN, Torres-Cabala CA, Curry JL, Fang P, Thomas VD, Huen AO. Aggressive primary cutaneous anaplastic large cell lymphoma with massive bilateral upper limb involvement at relapse. JAAD Case Rep 17(None):34-37, 2021. e-Pub 2021. PMID: 34692965.
- Bao A, Barsky AR, Maxwell R, Bekelman JE, Both S, Christodouleas JP, Deville C, Fang P, Tochner ZA, Vapiwala N. Long-term Clinical Outcomes in Favorable Risk Prostate Cancer Patients Receiving Proton Beam Therapy. Int J Part Ther 8(4):14-24, 2021. e-Pub 2021. PMID: 35530185.
- Al Feghali KA, Fang P (co-first author), Gule-Monroe M, Milgrom S, Khoury JD, Gunther JR, Sheu T, Nair R, Ahmed S, Steiner R, Strati P, Shpall EJ, Nieto YL, Hosing C, Nastoupil LJ, Westin JR, Neelapu SS, Fowler N, Flowers C, Pinnix CC, Dabaja BS. Prognostic value of disease distribution in secondary central nervous system diffuse large B cell lymphoma treated with radiation therapy. Leuk Lymphoma 62(10):1-8, 2021. e-Pub 2021. PMID: 33942701.
- Augustyn A, Medeiros LJ, Ludmir EB, Gunther J, Fang P, Li S, Ok CY, Bankston ME, Verma V, Pasalic D, Ahmed S, Nastoupil LJ, Westin JR, Strati P, Neelapu SS, Nair R, Steiner RE, Iyer SP, Rodriguez A, Fayad LE, Flowers CR, Dabaja BS, Pinnix CC. The impact of cell-of-origin, MYC/Bcl-2 dual expression and MYC rearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with combined modality therapy. Leuk Lymphoma 62(6):1-12, 2021. e-Pub 2021. PMID: 33480830.
- Fang P, Gunther JR, Pinnix CC, Dong W, Strati P, Nastoupil LJ, Steiner RE, Ahmed S, Damron EP, Fowler N, Nair R, Westin JR, Neelapu S, Ha CS, Dabaja BS. A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) Lymphoma. Int J Radiat Oncol Biol Phys 109(5):1414-1420, 2021. e-Pub 2021. PMID: 33309978.
- Fang PQ, Gunther JR, Wu SY, Dabaja BS, Nastoupil LJ, Ahmed S, Neelapu SS, Pinnix CC. Radiation and CAR T-cell Therapy in Lymphoma: Future Frontiers and Potential Opportunities for Synergy. Front Oncol 11(None):648655, 2021. e-Pub 2021. PMID: 33842363.
- Brooks, ED, Fang, PQ, Pinnix, CC. Salvage radiotherapy for primary refractory and relapsed diffuse large B-Cell lymphoma. British Journal of Radiology 94(1127), 2021. e-Pub 2021. PMID: 34378402.
- Christopherson KM, Gunther JR, Fang P, Peterson SL, Roach KE, Wong PF, Mirkovic D, Lim TY, Wang H, Wang XA, Wang C, Garcia J, Dabaja BS, Pinnix CC. Decreased heart dose with deep inspiration breath hold for the treatment of gastric lymphoma with IMRT. Clin Transl Radiat Oncol 24(None):79-82, 2020. e-Pub 2020. PMID: 32642563.
- Pinnix CC, Gunther JR, Fang P, Bankston ME, Milgrom SA, Boyce D, Lee HJ, Nair R, Steiner R, Strati P, Ahmed S, Iyer SP, Westin J, Parmar S, Rodriguez MA, Nastoupil L, Neelapu S, Flowers C, Dabaja BS. Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy. JAMA Netw Open 3(9):e2013935, 2020. e-Pub 2020. PMID: 32990738.
- Glober G, Gunther J, Fang P, Milgrom S, Korivi BR, Jensen CT, Wagner-Bartak NA, Ahmed S, Lee HJ, Nair R, Steiner R, Parmar S, Iyer S, Westin J, Fayad L, Rodriguez MA, Neelapu S, Nastoupil L, Flowers CR, Dabaja BS, Pinnix CC. Imaging Surveillance of Limited-stage Classic Hodgkin Lymphoma Patients After PET-CT-documented First Remission. Clin Lymphoma Myeloma Leuk 20(8):533-541, 2020. e-Pub 2020. PMID: 32291233.
- Pinnix CC, Gunther JR, Dabaja BS, Strati P, Fang P, Hawkins MC, Adkins S, Westin J, Ahmed S, Fayad L, Lee HJ, Nair R, Steiner RE, Iyer SP, Rodriguez MA, Wang M, Flowers C, Neelapu SS, Nastoupil LJ. Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma. Blood Adv 4(13):2871-2883, 2020. e-Pub 2020. PMID: 32589728.
- Gunther JR, Pinnix CC, Glober GR, Christopherson KM, Fang P, Lee HJ, Ahmed S, Steiner RE, Nair R, Strati P, Neelapu SS, Nastoupil LJ, Dabaja BS. Partial omission of bleomycin for early-stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes?. EJHaem 1(1):272-276, 2020. e-Pub 2020. PMID: 32864660.
- Ng SP, Cardenas CE, Elhalawani H, Pollard C, Elgohari B, Fang P, Meheissen M, Guha-Thakurta N, Bahig H, Johnson JM, Kamal M, Garden AS, Reddy JP, Su SY, Ferrarotto R, Frank SJ, Brandon Gunn G, Moreno AC, Rosenthal DI, Fuller CD, Phan J. Comparison of tumor delineation using dual energy computed tomography versus magnetic resonance imaging in head and neck cancer re-irradiation cases. Phys Imaging Radiat Oncol 14(None):1-5, 2020. e-Pub 2020. PMID: 33458306.
- Pezzi TA, Fang P (co-first author), Gjyshi O, Feng L, Liu S, Komaki R, Lin SH. Rates of Overall Survival and Intracranial Control in the Magnetic Resonance Imaging Era for Patients with Limited-Stage Small Cell Lung Cancer with and without Prophylactic Cranial Irradiation. JAMA Netw Open 3(4):e201929, 2020. e-Pub 2020. PMID: 32236532.
- Ludmir EB, Subbiah IM, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Mandel JJ, Fang P, Smith BD, Smith GL, Pinnix CC, Sedrak MS, Kimmick GG, Stinchcombe TE, Jagsi R, Thomas CR, Fuller CD, VanderWalde NA. Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials. J Geriatr Oncol 11(3):451-454, 2020. e-Pub 2020. PMID: 31711757.
- Borggreve AS, Goense L, van Rossum PSN, Heethuis SE, van Hillegersberg R, Lagendijk JJW, MGEH L, ALHMW VL, Mook S, Ruurda JP, van Vulpen M, Voncken FEM, Aleman BMP, Bartels-Rutten A, Ma J, Fang P, Musall BC, Lin SH, Meijer GJ. Preoperative prediction of pathologic response to neoadjuvant chemoradiotherapy in patients with esophageal cancer using 18F-FDG PET/CT and DW-MRI: a prospective multicenter study. Int J Radiat Oncol Biol Phys 106(5):998-1009, 2020. e-Pub 2020. PMID: 31987972.
- Azad TD, Chaudhuri AA, Fang P, Qiao Y, Esfahani MS, Chabon JJ, Hamilton EG, Yang YD, Lovejoy A, Newman AM, Kurtz DM, Jin M, Schroers-Martin J, Stehr H, Liu CL, Hui AB, Patel V, Maru D, Lin SH, Alizadeh AA, Diehn M. Circulating tumor DNA analysis for detection of minimal residual disease after chemoradiotherapy for localized esophageal cancer. Gastroenterology 158(3):494-505.e6, 2020. e-Pub 2020. PMID: 31711920.
- Sperduto PW, Fang P, Li J, Breen W, Brown PD, Cagney D, Aizer A, Yu JB, Chiang V, Jain S, Gaspar LE, Myrehaug S, Sahgal A, Braunstein S, Sneed P, Cameron B, Attia A, Molitoris J, Wu CC, Wang TJC, Lockney NA, Beal K, Parkhurst J, Buatti JM, Shanley R, Lou E, Tandberg DD, Kirkpatrick JP, Shi D, Shih HA, Chuong M, Saito H, Aoyama H, Masucci L, Roberge D, Mehta MP. Estimating Survival in Patients with Gastrointestinal Cancers and Brain Metastases: An Update of the Graded Prognostic Assessment for Gastrointestinal Cancers (GI-GPA). Clin Transl Radiat Oncol 18(None):39-45, 2019. e-Pub 2019. PMID: 31341974.
- Fang P, Jagsi R, He W, Lei X, Campbell EG, Giordano SH, Smith GL. Rising and Falling Trends in the Use of Chemotherapy and Targeted Therapy Near the End of Life in Older Patients with Cancer. J Clin Oncol 37(20):1721-1731, 2019. e-Pub 2019. PMID: 31141431.
- Sperduto PW, Fang P, Li J, Breen W, Brown PD, Cagney D, Aizer A, Yu J, Chiang V, Jain S, Gaspar LE, Myrehaug S, Sahgal A, Braunstein S, Sneed P, Cameron B, Attia A, Molitoris J, Wu CC, Wang TJC, Lockney N, Beal K, Parkhurst J, Buatti JM, Shanley R, Lou E, Tandberg DD, Kirkpatrick JP, Shi D, Shih HA, Chuong M, Saito H, Aoyama H, Masucci L, Roberge D, Mehta MP. Survival and Prognostic Factors in Patients with Gastrointestinal Cancers and Brain Metastases: Have We Made Progress?. Transl Res 208(None):63-72, 2019. e-Pub 2019. PMID: 30885538.
- Ho JC, Fang P (co-first author), Cardenas CE, Mohamed ASR, Fuller CD, Allen PK, Bhosale PR, Frumovitz MM, Jhingran A, Klopp AH. Volumetric Assessment of Apparent Diffusion Coefficient Predicts Outcome Following Chemoradiation for Cervical Cancer. Radiother Oncol 135(None):58-64, 2019. e-Pub 2019. PMID: 31015171.
- Verma V, Sleightholm RL, Fang P, Ryckman JM, Lin C. National Cancer Data Base Report of Nonmetastatic Esophageal Small Cell Carcinoma. Cancer Med 7(12):6365-6373, 2018. e-Pub 2018. PMID: None.
- Fang P, Musall BC, Son JB, Moreno AC, Hobbs BP, Carter BW, Fellman BM, Mawlawi O, Ma J, Lin SH. Multimodal Imaging of Pathologic Response to Chemoradiation in Esophageal Cancer. Int J Radiat Oncol Biol Phys 102(4):996-1001, 2018. e-Pub 2018. PMID: 29685377.
- Fang P, Jiang W, Davuluri R, Xu C, Krishnan S, Mohan R, Koong AC, Hsu CC, Lin SH. High lymphocyte count during neoadjuvant chemoradiotherapy is associated with improved pathologic complete response in esophageal cancer. Radiother Oncol 128(3):584-590, 2018. e-Pub 2018. PMID: 29530432.
- Goense L, Ruurda JP, Carter BW, Fang P, Ho L, Meijer GJ, van Hillegersberg R, Hofstetter WL, Lin SH. Prediction and Diagnosis of Interval Metastasis after Neoadjuvant Chemoradiotherapy for Esophageal Cancer Using 18F-FDG PET/CT. Eur J Nucl Med Mol Imaging 45(10):1742-1751, 2018. e-Pub 2018. PMID: 29663014.
- Shiraishi Y, Fang P (co-first author), Xu C, Song J, Krishnan S, Koay EJ, Mehran RJ, Hofstetter WL, Blum-Murphy M, Ajani JA, Komaki R, Minsky B, Mohan R, Hsu CC, Hobbs BP, Lin SH. Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy. Radiother Oncol 128(1):154-160, 2018. e-Pub 2018. PMID: 29248170.
- Fang P, He W, Gomez D, Hoffman KE, Smith BD, Giordano SH, Jagsi R, Smith GL. Racial disparities in guideline-concordant cancer care and mortality in the United States. Adv Radiat Oncol 3(3):221-229, 2018. e-Pub 2018. PMID: 30202793.
- Moreno AC, Haque W, Verma V, Fang P, Lin SH. Concurrent Versus Sequential Chemoradiation Therapy in Completely Resected Pathologic N2 Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Data Base. Ann Surg Oncol 25(5):1245-1253, 2018. e-Pub 2018. PMID: 29484562.
- Verma V, Moreno AC, Haque W, Fang P, Lin SH. Sequential Versus Concurrent Chemoradiation Therapy by Surgical Margin Status in Resected Non-Small Cell Lung Cancer. J Natl Compr Canc Netw 16(5):508-516, 2018. e-Pub 2018. PMID: 29752325.
- Fang P, Boehling NS, Koay EJ, Bucheit AD, Jakob JA, Settle SH, Brown PD, Davies MA, Sulman EP. Melanoma brain metastases harboring BRAF V600K or NRAS mutations are associated with an increased local failure rate following conventional therapy. J Neurooncol 137(1):67-75, 2018. e-Pub 2018. PMID: 29198052.
- Barua S, Fang P (co-first author), Sharma A, Fujimoto J, Wistuba I, Rao AUK, Lin SH. Spatial interaction of tumor cells and regulatory T cells correlates with survival in non-small cell lung cancer. Lung Cancer 117(None):73-79, 2018. e-Pub 2018. PMID: 29409671.
- Fang P, Shiraishi Y, Verma V, Jiang W, Song J, Hobbs BP, Lin SH. Lymphocyte-Sparing Effect of Proton Therapy in Patients with Esophageal Cancer Treated with Definitive Chemoradiation. Int J Part Ther 4(3):23-32, 2018. e-Pub 2018. PMID: 30079369.
- Pezzi TA, Tang C, Swanick CW, Fang P, Hess K, Xu T, Hahn SM, Chang JY, Liao Z, Gomez D. Patterns and correlates of treatment failure in relation to isodose distribution in non-small cell lung cancer: An analysis of 1522 patients in the modern era. Radiother Oncol 125(2):325-330, 2017. e-Pub 2017. PMID: 29054376.
- Woodward WA, Fang P (co-first author), Arriaga L, Gao H, Cohen EN, Reuben JM, Valero V, Le-Petross H, Middleton LP, Babiera GV, Strom EA, Tereffe W, Hoffman K, Smith BD, Buchholz TA, Perkins GH. A phase 2 study of capecitabine and concomitant radiation in women with advanced breast cancer. Int J Radiat Oncol Biol Phys 99(4):777-783, 2017. e-Pub 2017. PMID: 28843370.
- An Y, Jiang W, Kim BYS, Qian JM, Tang C, Fang P, Logan J, D'Souza NM, Haydu LE, Wang XA, Hess KR, Kluger H, Glitza IC, Mahajan A, Welsh JW, Lin SH, Yu JB, Davies MA, Hwu P, Sulman EP, Brown PD, Chiang VLS, Li J. Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial control. Radiother Oncol 125(1):80-88, 2017. e-Pub 2017. PMID: 28916225.
- Davuluri R, Jiang W, Fang P, Xu C, Komaki R, Gomez DR, Welsh J, Cox JD, Crane CH, Hsu CC, Lin SH. Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy. Int J Radiat Oncol Biol Phys 99(1):128-135, 2017. e-Pub 2017. PMID: 28816138.
- Fang P, He W, Gomez DR, Hoffman KE, Smith BD, Giordano SH, Jagsi R, Smith GL. Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States. Int J Radiat Oncol Biol Phys 98(4):748-757, 2017. e-Pub 2017. PMID: 28366580.
- Fang P, Jiang W, Allen P, Glitza I, Guha N, Hwu P, Ghia A, Phan J, Mahajan A, Tawbi H, Li J. Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma. J Neurooncol 133(3):595-602, 2017. e-Pub 2017. PMID: 28500560.
- Fang P. Internal Mammary Misfortune. Int J Radiat Oncol Biol Phys 97(3):447, 2017. e-Pub 2017. PMID: 28126294.
- Fang P, Swanick CW, Pezzi TA, Liao Z, Welsh J, Lin SH, Gomez DR. Outcomes and toxicity following high-dose radiation therapy in 15 fractions for non-small cell lung cancer. Pract Radiat Oncol 7(6):433-441, 2017. e-Pub 2017. PMID: 28428017.
- D'Souza NM, Fang P, Logan J, Yang J, Jiang W, Li J. Combining Radiation Therapy with Immune Checkpoint Blockade for Central Nervous System Malignancies. Front Oncol 6(None):212, 2016. e-Pub 2016. PMID: 27774435.
- Fang P, Batra S, Hollander AB, Lin A, Hill-Kayser CE, Levin LM, Mupparapu M, Thompson RF. Development and evaluation of a standardized method and atlas for contouring primary and permanent dentition. Dentomaxillofac Radiol 44(7):2015501034, 2015. e-Pub 2015. PMID: None.
- Fang P, Mick R, Deville C, Both S, Bekelman JE, Christodouleas JP, Guzzo TJ, Tochner Z, Hahn SM, Vapiwala N. A Case-Matched Study of Toxicity Outcomes After Proton Therapy and Intensity-Modulated Radiation Therapy for Prostate Cancer. Cancer 121(7):1118-27, 2015. e-Pub 2015. PMID: 25423899.
- Fang P, Tan KS, Grover S, McFadien MK, Troxel AB, Lin L. Psychosocial Encounters Correlates with Higher Patient-Reported Functional Quality of Life in Gynecological Cancer Patients Receiving Radiotherapy. Radiat Oncol 10(None):34, 2015. e-Pub 2015. PMID: 25657054.
- Zou W, Yin L, Shen J, Corradetti MN, Kirk M, Munbodh R, Fang P, Jabbour SK, Simone CB, Yue NJ, Rengan R, Teo BK. Dynamic Simulation of Motion Effects in IMAT Lung SBRT. Radiat Oncol 9(None):225, 2014. e-Pub 2014. PMID: 25365935.
- Alonso-Basanta M, Fang P (co-first author), Maity A, Hahn SM, Lustig RA, Dorsey JF. A Phase I Study of Nelfinavir Concurrent with Temozolomide and Radiotherapy in Patients with Glioblastoma Multiforme. J Neurooncol 116(2):365-372, 2014. e-Pub 2014. PMID: 24194293.
- Fang P, Tan KS, Troxel AB, Rengan R, Freedman G, Lin LL. High Body Mass Index is Associated with Worse Quality of Life in Breast Cancer Patients Receiving Radiotherapy. Breast Cancer Res Treat 141(1):125-33, 2013. e-Pub 2013. PMID: 23942874.
- Millen JC, Ginde AA, Anderson AT, Fang P, Camargo CA. Multicenter Study of Knowledge About Human Papilloma Virus and Attitudes Among Emergency Department Patients. J Pediatr Adolesc Gynecol 22(6):356-9, 2009. e-Pub 2009. PMID: 19576825.
Abstracts
- Manzar GS, Wu SY, Dudzinski SO, Jallouk A, Yoder AK, Nasr LF, Corrigan KL, Gunther JL, Ahmed S, Fayad L, Nair R, Steiner R, Westin J, Neelapu SS, Dabaja B, Strati P, Nastoupil L, Pinnix CC, Fang P. Outcomes with Bridging Radiation Therapy Prior to CAR-T Cell Therapy in Patients with Aggressive B Cell Lymphomas. Int J Radiat Oncol Biol Phys 117(2S):e483-484, 2023. e-Pub 2023. PMID: None.
- Cha E, Manzar GS, Corrigan KL, Yoder AK, Schrank BR, Nasr LF, Gunther JR, Strati P, Ahmed S, Fayad L, Nair R, Steiner R, Westin J, Nastoupil L, Neelapu SS, Pinnix CC, Dabaja B, Wu SY, Fang P. Outcomes and Toxicities in Patients with Diffuse Large B-Cell Lymphoma of the Gastrointestinal Tract. Int J Radiat Oncol Biol Phys 117(2S):E460, 2023. e-Pub 2023. PMID: None.
- Manzar GS, Wu SY, Dudzinski SO, Rooney MK, Jallouk A, Yoder AK, Nasr LF, Gunther JR, Sallard G, Ahmed S, Fayad L, Nair R, Steiner R, Westin J, Nastoupil L, Neelapu SS, Dabaja B, Pinnix CC, Strati P, Fang P. Characterization of Lymphopenia during Bridging Radiation Therapy Prior to CAR-T Cell Therapy in Patients with Aggressive B Cell Lymphomas. Int J Radiat Oncol Biol Phys 117(2S):S53-S54, 2023. e-Pub 2023. PMID: None.
- Wu SY, Gunther JR, Manzar GS, Corrigan KL, Damron EP, Schrank BR, Nasr LF, Chihara D, Malpica Castillo LE, Nair R, Steiner R, Jain P, Neelapu SS, Samaniego F, Rodriguez MA, Strati P, Nastoupil L, Dabaja B, Pinnix CC, Fang P. Ultra Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung. Int J Radiat Oncol Biol Phys 117(2S):e492, 2023. e-Pub 2023. PMID: None.
- Schrank BR, Manzar GS, Wu SY, Gunther JR, Fang P, Jabbour EJ, Lim TY, Daver NG, Cykowski MD, Fuller GN, Cachia D, Kamiya-Matsuoka C, Woodman KH, DiNardo CD, Jain N, Short NJ, Sasaki K, Dabaja B, Kantarjian HM, Pinnix CC. Dorsal Column Myelopathy Following Intrathecal Chemotherapy for Leukemia. Int J Radiat Oncol Biol Phys 117(2S):e486-e487, 2023. e-Pub 2023. PMID: None.
- Manzar G, Wu S, Khan M, Corrigan K, Yoder A, Gunther J, Thomas S, Manasanch E, Lee H, Lim T, Amini B, Lin P, Orlowski R, Patel K, Becnel M, Kaufman G, Weber D, Dabaja B, Pinnix C, Fang P. Outcome of Patients with Central Nervous System Multiple Myeloma (CNS-MM) Treated with CNS-Directed Radiation Therapy. Int J Radiat Oncol Biol Phys 114(3):e358, 2022. e-Pub 2022. PMID: None.
- Champlin RE, Lustig EB, Bashir Q, Oran B, Kornblau SM, Hosing C, Alousi AM, Popat U, McCarty JM, Thall P, Dabaja BS, Liu WH, Dang G, Castro K, Ramirez A, Spiotto M, Wu S, Fang P, Kaur I, Rezvani K, Cooper L, Reisner Y. First in Human Study of Anti-Viral Veto Cells Enabling Successful Engraftment without Severe Gvhd in Non-Myeloablative T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation (HSCT). Blood 140(Supl 1):2120-2122, 2022. e-Pub 2022. PMID: None.
- Damron EP, Qazilbash M, Fang P, Wu SY, Dabaja B, Rondon G, Hosing C, Champlin R, Bashir Q, Shpall EJ, Knafl M, Lee H, Manasanch EE, Patel K, Kaufman G, Thomas S, Orlowski R, Weber D, Pinnix CC, Gunther JR. Radiation Therapy can be Safely Incorporated into Pre-Transplant Treatment Regimens for Patients with Multiple Myeloma. Int J Radiat Oncol Biol Phys 111(3S):S81, 2021. e-Pub 2021. PMID: None.
- Wu SY, Fang P, Huen AO, Iyer SP, Nair R, Steiner R, Castillo LEM, Duvic M, Ahmed S, Jain P, Fayad L, Strati P, Westin J, Neelapu SS, Nastoupil L, Pinnix CC, Dabaja B, Gunther JR. Concurrent Radiation Therapy with the Antibody-Drug Conjugates Brentuximab Vedotin and Polatuzumab Vedotin. Int J Radiat Oncol Biol Phys 111(3S):e301, 2021. e-Pub 2021. PMID: None.
- Khan M, Mohamed S, Becnel M, Thomas S, Manasanch E, Lee H, Iyer S, Qazilbash M, Bashir Q, Srour S, Wu S, Fang P, Gunther J, Pinnix C, Amini B, Lin P, Dabaja B, Patel K, Weber D, Orlowski RZ, Kaufman G. Central nervous system Multiple Myeloma (CNS-MM), presentation and outcomes in an Era of anti-CD38 and pomalidomide inclusive therapies. Clin Lymphoma Myeloma Leuk 21(S2):S146-S146, 2021. e-Pub 2021. PMID: None.
- Pinnix C, Damron E, Gunther J, Fang P, Wu S, Dabaja B, Neelapu S, Nastoupil L, Ahmed S, Strati P, Westin J, Fayad L, Steiner R, Nair R, Gombos D, Fowler N. Primary intraocular lymphoma: Outcomes and toxicity after radiation therapy. Am J Clin Oncol 44(10):S29-S30, 2021. e-Pub 2021. PMID: None.
- Srour SA, Xu J, Al-Juhaishi T, Steiner RE, Ensor J, Ahmed S, Parmar S, Strati P, Nastoupil LJ, Nieo Y, Hosing C, Lee HJ, Westin J, Fowler NH, Fayad L, Dabaja BS, Pinnix CC, Gunther JR, Fang P, Samaniego F, Jain P, Champlin RE, Khouri IF, Wang M, Miranda RN, Vega F, Neelapu SS, Flowers C, Iyer SP. Retrospective Review of Prognostic and Predictors Markers in Newly Diagnosed Angioimmunoblastic T Cell Lymphoma at UT MD Anderson Cancer Center. Blood 136(Supl 1):None, 2020. e-Pub 2020. PMID: None.
- Fang P, Augustyn A, He J, Qiao Y, Lee P, Koong AC, Heymach J, Tsao A, Petrosino J, Lin SH. Relationship Between Buccal Microbiome Diversity and Overall Survival in Locally Advanced NSCLC Patients Treated with Chemoradiation and Immunotherapy. Int J Radiat Oncol Biol Phys 108(3):S109, 2020. e-Pub 2020. PMID: None.
- Al Hadidi S, Nair R, Steiner RE, Ahmed S, Strati P, Parmar S, Iyer SP, Gunther JR, Pinnix CC, Dabaja BS, Nieto Y, Samaniego F, Cuglievan B, Jain P, Fang P, Miranda RN, Medeiros J, Feng L, Chuang H, Wang M, Lee JH. Association of Epstein-Barr Virus with Advanced Stage and Survival Outcomes in Classic Hodgkin's Lymphoma. Blood 136(Supl 1):None, 2020. e-Pub 2020. PMID: None.
- Nair R, Al Hadidi S, Steiner RE, Ahmed S, Strati P, Parmar S, Iyer SP, Fang P, Gunther JR, Jain P, Pinnix CC, Dabaja BS, Nieto Y, Samaniego F, Cuglievan B, Miranda RN, Medeiros LJ, Feng L, Chuang H, Wang M, Lee HJ. Association of Vitamin D Deficiency with Inferior Treatment Outcomes in Patients with Newly Diagnosed Classic Hodgkin Lymphoma: MD Anderson Cancer Center Experience. Blood 136(Supl 1):None, 2020. e-Pub 2020. PMID: None.
- Al Hadidi S, Nair R, Steiner RE, Ahmed S, Strati P, Parmar S, Iyer SP, Gunther JR, Pinnix CC, Dabaja BS, Nieto Y, Samaniego F, Cuglievan B, Jain P, Fang P, Miranda RN, Medeiros LJ, Feng L, Chuang H, Wang M, Lee HJ. Association of Smoking with Advanced Stage and Survival Outcomes in Classic Hodgkin's Lymphoma. Blood 136(Supl 1):None, 2020. e-Pub 2020. PMID: None.
- Al Hadidi S, Nair R, Steiner RE, Ahmed S, Strati P, Parmar S, Iyer SP, Gunther JR, Pinnix CC, Dabaja BS, Nieto Y, Samaniego F, Cuglievan B, Jain P, Fang P, Miranda RN, Medeiros J, Feng L, Chuang H, Wang M, Lee HJ. Real Life Treatment Alterations of Frontline Therapies in Classic Hodgkin's Lymphoma. Blood 136(Supl 1):None, 2020. e-Pub 2020. PMID: None.
- Steiner RE, Becnel MR, Cuglievan B, Nair R, Singh P, Strati P, Jain P, Ahmed S, Samaniego F, Gunther JR, Pinnix CC, Fang P, Dabaja BS, Feng L, Lee HJ. Brentuximab Vedotin with Chemotherapy in Frontline Treatment of Classic Hodgkin Lymphoma Nodular Sclerosis Syncytial Variant. Blood 136(Supl 1):None, 2020. e-Pub 2020. PMID: None.
- Nair R, Pinnix CC, Gunther JR, Strati P, Westin J, Fayad L, Hagemeister FB, Iyer SP, Nastoupil LJ, Parmar S, Rodriguez MA, Steiner R, Dabaja BS, Fang P, Flowers C, Noorani M, Feng L, Neelapu SS, Ahmed S, Lee HJ. MD Anderson experience of immune checkpoint inhibitor therapy in classical Hodgkin lymphoma. J Clin Oncol 38(15 S), 2020. e-Pub 2020. PMID: None.
- Steiner R, Cramer FM, Singh P, Becnel M, Alcedo PE, Chin CK, Cuglievan B, Strati P, Ahmed S, Samaniego F, Nair R, Gunther JR, Pinnix CC, Fang P, Dabaja BS, Feng L, Lee HJ. Brentuximab vedotin with chemotherapy for advanced stage untreated classic Hodgkin's lymphoma in a real-world setting. J Clin Oncol 38(15 S), 2020. e-Pub 2020. PMID: None.
- van Rossum PSN, Fang P, Musall B, Son JB, Fellman B, Hobbs B, Ma J, Lin SH. Final Trial Results of Repeated Diffusion-Weighted MRI and FDG-PET Imaging for the Prediction of Response to Chemoradiation Therapy in Esophageal Cancer. Int J Radiat Oncol Biol Phys 105(1S):S59-S60, 2019. e-Pub 2019. PMID: None.
- Borggreve A, Goense L, van Rossum PSN, Heethuis SE, van Hillegersberg R, Lagendijk JJW, ALHMW VL, Mook S, Ruurda JP, van Vulpen M, Voncken FE, Aleman BMP, Bartels-Rutten A, Ma J, Fang P, Musall BC, Lin SH, Meijer GJ. PO-0798 Response Assessment to Neoadjuvant Chemoradiotherapy for Esophageal Cancer Using PET/CT and DW-MRI. Radiotherapy and Oncology 133(Suppl 1):S413-s414, 2019. e-Pub 2019. PMID: None.
- Borggreve A, Goense L, Van Rossum PSN, HHeethuis SE, Van Hillegersberg R, Lagendijk JJW, ALHMW VL, Mook S, Ruurda JP, Van Vulpen M, Voncken FE, Aleman BMP, Bartels-Rutten A, Ma J, Fang P, Musall BC, Lin SH, Meijer GJ. Response Assessment to Neoadjuvant Chemoradiotherapy for Esophageal Cancer Using PET/CT and DW-MRI. Radiotherapy and Oncology 133(Suppl 1):S413-S414, 2019. e-Pub 2019. PMID: None.
- Fang P, Lei X, Herman J, Koong A, Das P, Koay E, Giordano S, Smith GL. Costs of SBRT vs Conventional Treatments for Unresectable Pancreas Adenocarcinoma. Int J Radiat Oncol Biol Phys 102(3S):e72, 2018. e-Pub 2018. PMID: None.
- Fang P, Bloom E, Woodward W, Stauder M, Tereffe W, Chun S, Schlembach P, Mayo L, Ahmad N, Arzu I, Reed V, Chronowski G, Delclos ME, Smith BD. A Phase 2 Study of Hypofractionated Partial Breast Irradiation (HF-PBI) in Women with Early-Stage Breast Cancer. Int J Radiat Oncol Biol Phys 102(3S):e584-585, 2018. e-Pub 2018. PMID: None.
- Sperduto PW, Fang P, Li J, Breen W, Brown PD, Cagney D, Aizer A, Myrehaug S, Sahgal A, Jain S, Gaspar LE, Cameron B, Attia A, Molitoris J, Wu C, Wang T, Lockney N, Beal K, Parkhurst J, Buatti J, Shanley R, Lou E, Tandberg DD, Kirkpatrick JP, Shi D, Shih H, Chuong M, Saito H, Aoyama H, Masucci L, Roberge D, MMehta MP. Survival and Prognostic Factors in Patients with Gastrointestinal Cancers and Brain Metastases. Int J Radiat Oncol Biol Phys 102(3S):e314-315, 2018. e-Pub 2018. PMID: None.
- Fang P, Musall BC, Song JB, Moreno AC, Hobbs BP, Carter BW. (OA34) Multimodal Imaging of Pathologic Response to Chemoradiation in Esophageal Cancer. Int J Radiat Oncol Biol Phys 101(2, Supl 1):e15, 2018. e-Pub 2018. PMID: None.
- Musall B, Lin SH, Fang P, Carter B, Moreno A, Sanders J, Son JB, Ma J. Automated Contouring and ADC Measurement of Esophageal Cancer with a Fully Convolutional Network. Proceedings of the International Society for Magnetic Resonance in Medicine None(None):None, 2018. e-Pub 2018. PMID: None.
- Musall B, Lin S, Fang P, Carter B, Son J, Fellman B, Ma J. Does Diffusion Kurtosis Imaging Add Value for Early Prediction of Response to Neoadjuvant Chemoradiation in Esophageal Cancer?. Medical Physics 45(6):E405-E406, 2018. e-Pub 2018. PMID: None.
- Fang P, Musall B, Ma J, Son JB, Fellman B, Hobbs B, Lin SH. Interim FDG-PET Imaging as an Early Response Biomarker for Pathologic Response to Chemoradiation in Esophageal Cancer. Int J Radiat Oncol Biol Phys 99(2S):S14-15, 2017. e-Pub 2017. PMID: None.
- Fang P, Shiraishi Y, Jiang W, Song J, Hobbs BP, Lin S. (S019) Lymphocyte-Sparing Effect of Proton Therapy in Patients with Esophageal Cancer. Int J Radiat Oncol Biol Phys 98(2, Supl 1):e6, 2017. e-Pub 2017. PMID: None.
- Azad TD, Chaudhuri A, Newman AM, Stehr H, Schroers-Martin J, Chabon JJ, Fang P, Qiao Y, Liao ZX, Komaki R, Alizadeh AA, Lin SH, Diehn M. Circulating Tumor DNA Analysis for Outcome Prediction in Localized Esophageal Cancer. J Clin Oncol 35(15):4055-4055, 2017. e-Pub 2017. PMID: None.
- Fang P, Rao X, Wang J, Maru D, Lin SH. Differential Expression of Immuno-oncologic Genes in Esophageal Cancer Patients with Complete Pathologic Response to Chemoradiation. Int J Radiat Oncol Biol Phys None(None):None, 2016. e-Pub 2016. PMID: None.
- Davuluri R, Jiang W, Fang P, Xu C, Komaki R, Cox JD, Hsu CC, Lin SH. Absolute Lymphocyte Count Nadir During Chemoradiation as a Prognostic Indicator of Esophageal Cancer Survival Outcomes. Int J Radiat Oncol Biol Phys 96(S2):e177, 2016. e-Pub 2016. PMID: None.
- Jiang W, Davuluri R, Fang P, Xu C, Welsh JW, Crane CH, Komaki R Cox JD, Hsu CC, Lin SH. Circulating Lymphocyte Count During Neoadjuvant Chemoradiation Therapy for Esophageal Cancer as a Predictive Biomarker of Pathologic Complete Response. Int J Radiat Oncol Biol Phys 96(2S):S151, 2016. e-Pub 2016. PMID: None.
- Lin SH, Mansfield JR, Rao X, Jiang W, Fang P, Roman K, Wang C, Komaki R, Fujimoto J, Wistuba I, Wang J, Hoyt CC. Multiplex In Situ Immunoprofiling and Survival Outcomes in Non-Small Cell Lung Cancer. Proceedings of the AACR Annual Meeting 76(14S):5123, 2016. e-Pub 2016. PMID: None.
- Lin SH, Mansfield JR, Rao X, Jiang W, Fang P, Roman K, Wang C, Komaki R, Hahn S, Swisher SG, Fujimoto J, Wistuba I, Wang J, Hoyt CC. Mulitplex In Situ Immunoprofiling and Survival Outcomes in Non-Small Cell Lung Cancer. Cancer Research 76(14S):5123, 2016. e-Pub 2016. PMID: None.
- Fang P, Jiang W, Kim BYS, Glitza IC, Mahajan A, Davies MA, DeMonte F, Hwu P, Sulman EP, Brown PD, Li J. Stereotactic Radiosurgery in the Setting of Immune Checkpoint Blockade Results in Improved Intracranial Control Compared to Whole Brain Irradiation for Greater than 3 Melanoma Brain Metastases. Proceedings of The American Radium Society Annual Meeting None(None):None, 2016. e-Pub 2016. PMID: None.
- Adams DL, Edelman MJ, Fang P, Jiang W, He J, Xu T, Gao H, Reuben JM, Qiao Y, Hahn S, Komaki R, Liao Z, Tang C, Lin SH. Sequential Tracking of PD-L1 Expression and RAD50 Induction in CTCs and Circulating Stromal Cells of Lung Cancer Patients during Treatment with Radiotherapy. Cancer Research 76(14S):4990, 2016. e-Pub 2016. PMID: None.
- Fang P, Jiang W, Kim BYS, Glitza IC, Mahajan A, Davies MA, DeMonte F, Hwu P, Sulman EP, Brown PD, Li J. Stereotactic Radiosurgery in the Setting of Immune Checkpoint Blockade Results in Improved Intracranial Control Compared to Whole Brain Irradiation for Greater than 3 Melanoma Brain Metastases. Proceedings of the Leksell Gamma Knife Society Annual Meeting None(None):None, 2016. e-Pub 2016. PMID: None.
- Fang P, Hobbs B, Fellman BM, Lin SH. Early Apparent Diffusion Coefficient Change During Neoadjuvant Chemoradiation Predicts Pathologic and Clinical Response in Esophageal Cancer. Int J Radiat Oncol Biol Phys 96(2S):E174, 2016. e-Pub 2016. PMID: None.
- Lin SH, Mansfield JR, Rao X, Jiang W, Fang P, Roman K, Wang C, Komaki R, Hahn S, Swisher SG, Fujimoto J, Wistuba I, Wang J, Hoyt CC. Abstract 5123: Multiplex In Situ Immunoprofiling and Survival Outcomes in Non-Small Cell Lung Cancer. Cancer Research 76(14 Supl), 2016. e-Pub 2016. PMID: None.
- Zhao Z, Phan J, Yang JN, Fang P, Guha-Thakurta N, McAleer MF, Wang X, Ferguson SD, Brown PD, Li J. Tumor Control of Peripherally Located Single Brain Metastases Utilizing the "Bubble" Skull Scaling Instrument in SRS Treatment Planning. Proceedings of the Leksell Gamma Knife Society Annual Meeting None(None):None, 2016. e-Pub 2016. PMID: None.
- Fang P, Rao X, Wang J, Maru D, Lin SH. Differential Expression of Immuno-oncologic Genes in Esophageal Cancer Patients. Int J Radiat Oncol Biol Phys 96(2S):E166, 2016. e-Pub 2016. PMID: None.
- Fang P, Jiang W, Davuluri R, Xu C, Welsh JW, Komaki R, Crane CH, Hsu CC, Lin SH. Immune Profile-to-Lymphocyte Ratios During Chemoradiation are Predictors of Clinical Outcomes in Esophageal Cancer. Int J Radiat Oncol Biol Phys 96(2S):E580-E581, 2016. e-Pub 2016. PMID: None.
- Adams DL, Edelman MJ, Fang P, Jiang W, He J, Xu T, Gao H, Reuben JM, Qiao Y, Hahn S, Komaki R, Liao Z, Tang CM, Lin SH. Abstract 4990: Sequential Tracking of PD-L1 Expression and RAD50 Induction in CTCs and Circulating Stromal Cells of Lung Cancer Patients During Treatment with Radiotherapy. Cancer Research 76(14 Supl), 2016. e-Pub 2016. PMID: None.
- Thompson RF, Fang P, Hollander A, Batra S, Lin A, Hill-Kayser C. PO-0784: Quantifying Variability among Clinician-Delineated Structures. Radiother Oncol 111(None):S53, 2014. e-Pub 2014. PMID: None.
- Fang P, Tan K, Grover S, Troxel A, Lin L. Psychological and Social Work Encounters Predict Higher Patient Reported Functional Quality of Life in Gynecologic Cancer Treatment. Int J Radiat Oncol Biol Phys 87(2S):S75, 2013. e-Pub 2013. PMID: None.
- Fang P, Alonso-Basanta M, Maity A, Hahn SM, Lustig RA, Dorsey JF. Phase I Study of Nelfinavir Concurrent with Temozolomide and Radiotherapy in Patients with Glioblastoma Multiforme. Int J Radiat Oncol Biol Phys 87(2S):S18, 2013. e-Pub 2013. PMID: None.
- Fang P, Tan KS, Troxel AB Rengan R, Freedman G, Lin L. High BMI Associated with Worse Quality of Life in Breast Cancer Patients Receiving Radiotherapy. Breast Cancer Res Treat 141:125–133, 2013. e-Pub 2013. PMID: None.
- Fang P, Holena DN, Weibe D, Kim P, Sims C, Sarani B, Schwab W, Pascual JL. Organ Donation Rates Remain Stagnant Despite the Steadily Rising Incidence and Lethality of Penetrating Brain Surgery. J Surg Res 172(2):348, 2012. e-Pub 2012. PMID: None.
Book Chapters
- Wu S, Dabaja B, Fang P. Radiobiologic Principles and the Role of Radiotherapy in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy. In: Radiobiologic Principles and the Role of Radiotherapy in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy. None. Elsevier Inc, 2024.
- Wu, SY, Dabaja, BS, Fang, PQ. Radiobiologic Principles and the Role of Radiotherapy in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy, 167-179, 2023.
- Fang P, Ho J, Frank S. Special Radiation Techniques: Brachytherapy, Stereotactic Body Radiation Therapy, Stereotactic Radiosurgery, Proton Therapy, and Oligometastases. In: Pocket Radiation Oncology. 1st. Wolters Kluwer, 2019.
- Fang P. Ependymoma. In: Radiation Oncology: A Question Based Review. 3rd. Wolters Kluwer, 2017.
- Fang P. DCIS. In: Radiation Oncology: A Question Based Review. 3rd. Wolters Kluwer, 2017.
- Fang P. Mesothelioma. In: Radiation Oncology: A Question Based Review. 3rd. Wolters Kluwer, 2017.
- Fang P. High Grade Glioma. In: Radiation Oncology: A Question Based Review. 3rd. Wolters Kluwer, 2017.
- Manzar G, Fang P. Diffuse Large B Cell Lymphoma. In: Pocket Radiation Oncology. 2. Wolters Kluwer.
Selected Presentations & Talks
Local Presentations
- 2021. Heme Special Techniques: Total Skin Electron Beam Therapy, Craniospinal Radiation, Total Body Radiation. Invited. NERO Hematology-Lymphoma Conference. Houston, Texas, US.
- 2021. Fang P, Poenisch F. Proton CSI in Leukemia. Invited. Proton, Physics, Planning and Outcomes (PPPO) Conference,. Houston, Texas, US.
Regional Presentations
- 2021. Heme Special Techniques: Total Skin Electron Beam Therapy, Craniospinal Radiation, Total Body Radiation. None. NERO Hematology-Lymphoma Conference, US.
National Presentations
- 2023. Educational Session: Role of RT and Dose in Multiple Myeloma: Knowns and Unknowns. Invited. San Diego, CA, US.
- 2023. Characterization of Lymphopenia during Bridging Radiation Therapy Prior to CAR-T Cell Therapy in Patients with Aggressive B cell Lymphomas. Conference. San Antonio, TX, US.
- 2022. Cutaneous/ subcutaneous involvement - an immune privileged site for poor outcomes in systemic peripheral T/ NK cell Lymphoma. Conference. New Orleans, LA, US.
- 2022. Outcome of Patients with Central Nervous System Multiple Myeloma (CNS-MM) Treated with CNS-Directed Radiation Therapy. Conference. San Antonio, TX, US.
- 2022. Radiotherapy in the Treatment of Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder. Conference. San Antonio, TX, US.
- 2022. Response Adapted Ultra Low Dose Radiation Therapy for the Definitive Management of Orbital Indolent B-Cell Lymphoma. Conference. San Antonio, TX, US.
- 2022. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder requires a multidisciplinary approach. Conference, US.
- 2021. Concurrent Radiation Therapy with the Antibody-Drug Conjugates Brentuximab Vedotin and Polatuzumab Vedotin. Conference. Chicago, IL, US.
- 2021. Radiation Therapy can be Safely Incorporated into Pre-Transplant Treatment Regimens for Patients with Multiple Myeloma. Conference. Chicago, IL, US.
- 2021. Radiation and Multiple Myeloma. Invited, US.
- 2020. A prospective trial of radiation therapy efficacy and toxicity for localized mucosa-associated lymphoid tissue (MALT) lymphoma. Conference. Miami, FL, US.
- 2020. Relationship Between Buccal Microbiome Diversity and Overall Survival in Locally Advanced NSCLC Patients Treated with Chemoradiation and Immunotherapy. Conference, US.
- 2019. Final Trial Results of Repeated Diffusion-Weighted MRI and FDG-PET Imaging for the Prediction of Response to Chemoradiation Therapy in Esophageal Cancer. Conference. Chicago, IL, US.
- 2019. Precision Medicine in Radiation Oncology. Invited. Seattle, WA, US.
- 2019. Precision Medicine in Radiation Oncology. Invited. Palo Alto, CA, US.
- 2018. Precision Medicine in Radiation Oncology. Invited. Atlanta, GA, US.
- 2018. Precision Medicine in Radiation Oncology. Invited. Columbus, OH, US.
- 2018. Precision Medicine in Radiation Oncology. Invited. Salt Lake City, UT, US.
- 2018. Precision Medicine in Radiation Oncology. Invited. New York, NY, US.
- 2018. Multimodal Imaging Pathologic Response in Esophageal Cancer. Conference. Orlando, FL, US.
- 2018. Outcomes and Costs of SBRT vs Conventional Treatments for Unresectable Pancreas Adenocarcinoma. Conference. San Antonio, TX, US.
- 2018. Precision Medicine in Radiation Oncology. Invited. Dallas, TX, US.
- 2018. Precision Medicine in Radiation Oncology. Invited. Rochester, MN, US.
- 2018. A Phase 2 Study of Hypofractionated Partial Breast Irradiation (HF-PBI) in Women with Early-Stage Breast Cancer. Conference. San Antonio, TX, US.
- 2017. Interim FDG-PET Imaging as an Early Response Biomarker for Pathologic Response to Chemoradiation in Esophageal Cancer. Conference. San Diego, CA, US.
- 2017. Racial Disparities in Guideline-Concordant Cancer Care. Conference. San Diego, CA, US.
- 2017. Lymphocyte-Sparing Effect of Proton Therapy in Patients with Esophageal Cancer. Conference. Colorado Springs, CO, US.
- 2016. Circulating Lymphocyte Count During Neoadjuvant Chemoradiation Therapy for Esophageal Cancer as a Predictive Biomarker of Pathologic Complete Response. Conference. Boston, MA, US.
- 2016. Immune Profile-to-Lymphocyte Ratios During Chemoradiation are Predictors of Clinical Outcomes in Esophageal Cancer. Conference. Boston, MA, US.
- 2016. Early Apparent Diffusion Coefficient Change during Neoadjuvant Chemoradiation Predicts Pathologic and Clinical Response in Esophageal Cancer. Conference. Boston, MA, US.
- 2016. Differential Expression of Immuno-oncologic Genes in Esophageal Cancer Patients with Complete Pathologic Response to Chemoradiation. Conference. Boston, MA, US.
- 2016. Stereotactic Radiosurgery in the Setting of Immune Checkpoint Blockade Results in Improved Intracranial Control Compared to Whole Brain Irradiation For Greater Than 3 Melanoma Brain Metastases. Conference. Philadelphia, PA, US.
- 2013. High BMI Associated with Worse Quality of Life in Breast Cancer Patients Receiving Radiotherapy. Conference. Atlanta, GA, US.
- 2013. Psychological and Social Work Encounters Predict Higher Patient Reported Functional Quality of Life in Gynecologic Cancer Treatment. Conference. Atlanta, GA, US.
- 2013. Phase I Study of Nelfinavir Concurrent with Temozolomide and Radiotherapy in Patients with Glioblastoma Multiforme. Conference. Atlanta, GA, US.
- 2011. The Steadily Increasing Incidence and Lethality of Penetrating Brain Injury: A Single GCS Point Drop Increases Mortality. Conference. Las Vegas, NV, US.
- 2011. mRECIST Does Not Predict Survival Following Chemoembolization of HCC. Conference. Chicago, IL, US.
International Presentations
- 2024. Meet the Professor: Hematologic Malignancies. Conference. Istanbul, TR.
- 2024. Radiation Treatment in the Era of Cellular and Immunotherapy in Hematologic Malignancies. Conference. Istanbul, TR.
- 2023. Bone Marrow Volume Irradiated and Risk of Cytopenias in Aggressive B-Cell Lymphoma Patients Bridged with Radiation Therapy for CART Cell Therapy. Conference. Lugano, CH.
- 2016. Stereotactic Radiosurgery in the Setting of Immune Checkpoint Blockade Results in Improved Intracranial Control Compared to Whole Brain Irradiation for Greater Than 3 Melanoma Brain Metastases. Conference. Amsterdam, NL.
- 2011. 3D Volumetric Assessment of Necrosis in Superior to RECIST and mRECIST in Predicting Survival Following Chemoembolization of HCC. Conference. New York City, US.
Formal Peers
- 2024. Radiation and Chimeric Antigen Receptor T cell (CAR-T) Therapy for Hematologic Malignancies. Visiting. Radiation and Chimeric Antigen Receptor T cell (CAR-T) Therapy for Hematologic Malignancies, US.
- 2024. Plasma Cell Neoplasms. Visiting. Plasma Cell Neoplasms, US.
- 2023. Plasma Cell Neoplasms. Visiting. Plasma Cell Neoplasms, US.
- 2022. Plasma Cell Neoplasms. Visiting. Plasma Cell Neoplasms, US.
- 2021. Proton CSI in Leukemia. Conference. Proton CSI in Leukemia. Houston, TX, US.
- 2020. Multiple Myeloma. Visiting. Multiple Myeloma, US.
- 2020. Multiple Myeloma. Visiting. Multiple Myeloma.
Grant & Contract Support
| Title: | Immune Cell Profile and Microbiome as a Predictive Biomarker for Cervical Cancer Response to Chemoradiation and Immunotherapy |
| Funding Source: | American Society of Clinical Oncology (ASCO) |
| Role: | PI |
| Title: | Immune Cell Profile and Microbiome as a Predictive Biomarker for Non-Small Cell Lung Cancer Response to Chemoradiation and Immunotherapy |
| Funding Source: | Radiological Society of North America (RSNA) |
| Role: | PI |
Patient Reviews
CV information above last modified February 25, 2025